Who owns the RETINALGENIX DNA/RNA GPS trademark?

The RETINALGENIX DNA/RNA GPS trademark is owned by Retinalgenix Technologies Inc..

What is the serial number for RETINALGENIX DNA/RNA GPS?

The USPTO serial number for RETINALGENIX DNA/RNA GPS is 98230742.

What is the registration number for RETINALGENIX DNA/RNA GPS?

RETINALGENIX DNA/RNA GPS is registered under USPTO registration number 0.

RET

USPTO Trademark Record

PENDING

RETINALGENIX DNA/RNA GPS

Q: What class is the RETINALGENIX DNA/RNA GPS trademark registered in?

The RETINALGENIX DNA/RNA GPS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

SN 98230742·Reg 0·Filed Oct 19, 2023

Owner Retinalgenix Technologies Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

RETINALGENIX DNA/RNA GPS (Serial No. 98230742), Registration No. 0, is a pending US trademark filed on Oct 19, 2023 by Retinalgenix Technologies Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

Statement of Use due: March 01, 2027143 days remaining

Mark Intelligence

RETINALGENIX DNA/RNA GPS (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 19, 2023

SERIAL

98230742

REG#

Owner

Applicant

Retinalgenix Technologies Inc.

Entity

Corporation

State

Address

1450 N. McDowell Blvd., Petaluma, CA, 94954

Country

Attorney

NameMegan E. Spitz

Law firm

Megan E. Spitz BLANK ROME LLP

Docket

164863-00104

Address

ONE LOGAN SQUARE, 8TH FLOOR, PHILADELPHIA, PA 19103, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateOct 19, 2023

Serial Number98230742

Registration No.0

Status DateSep 01, 2026

Published for OppositionJul 07, 2026

Mark TypeStandard characters

Attorney Docket164863-00104

Status DescriptionLive and pending, notice of allowance issued

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

24 events

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 01, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 07, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 07, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 01, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Jun 08, 2026

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 08, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Dec 05, 2025

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Jun 04, 2025

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 03, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Dec 03, 2024

PREVIOUS ALLOWANCE COUNT WITHDRAWN

SUSPENSION LETTER WRITTEN

Dec 03, 2024

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Dec 03, 2024

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Dec 03, 2024

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 02, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 02, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 02, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Sep 03, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Sep 03, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

May 31, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 31, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 31, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 15, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 25, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 23, 2023

NEW APPLICATION ENTERED

RETINALGENIX DNA/RNA GPS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Retinalgenix Technologies Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Megan E. Spitz

Resources

Company